Fitbit’s wearable devices and services will soon be included in Japanese tech company Fujitsu’s corporate wellness program. The program will offer 10,000 employees of Mitsubishi Motors Health Insurance Society a chance to earn redeemable fitness points using the Fitbit Charge 2 and a cloud-based data system, thereby making it one of Fitbit’s largest corporate wellness agreements in Japan. According to a statement, Fujitsu chose to partner with Fitbit due to their device’s ease of use, and because the fitness wearable company’s open API allows easy incorporation into Fujitsu’s existing Health Points environment. Read more
…
At Home Healthcare has tapped mobile care device company Vivify Health to provide technological support for patients transitioning from hospitals throughout Texas. Vivify’s remote patient monitoring kits will support At Home’s in-home nursing staff, and provide an additional layer of care that At Home believes will stand out from the rest of the state’s home care market. “We know that care transitions are particularly vulnerable times for these patients, which is why we are taking additional measures to assure they are continuously monitored by our professional care teams, enabled by the Vivify remote monitoring platform,” Michelle Maiorka, At Home’s vice president of Business Development and Transitional Care, said in a statement. Read more
…
Healthcare networking companies HealthXL and WEGO Health have announced a partnership to connect digital health companies with healthcare experts. Members on HealthXL’s platform will be able to access WEGO Health’s network through its member portal. The companies say that the integration will enable executives to more fluidly connect with experts in patient-driven digital health. Read more
…
GNS Healthcare, a precision medicine technology company, and the Swedish Cancer Institute have announced a collaboration to bring machine learning to breast cancer care. GNS’ Reverse Engineering and Forward Simulation (REFS) platform will provide computer models and a software interface tool linking clinical and molecular data to breast cancer patients’ treatments and outcomes. The partnership aims to provide caregivers with focused, personalized treatment options for their patients, and according to a statement could be a foundation for other more expansive programs. Read more
…
iMedicare, a pharmacy-focused decision automation platform available on tablets and computers through a web app, has teamed up with the Mirixa Corporation to bring patient counseling opportunities to thousands of community pharmacies. The new integration will be delivered alongside medication therapy management, adherence, and other services already implemented in the MirixaPro proprietary platform, and will allow pharmacies to make the most of medication-related opportunities by prioritizing available interventions for each patient. The partnership follows an announcement that iMedicare will be implementing other technologies, such as augmented reality, to deliver its services. Read more
…
Aliso Viejo, California-based Ambry Genetics will integrate its AmbryPort 2.0 (AP2) clinician ordering platform with FDNA’s Face2Gene suite of applications. The partnership will allow clinicians evaluating patients with Face2Gene’s AI and facial analysis technologies to securely pass data along to AP2, increasing the diagnostic value of patients’ genetic tests. FDNA CEO Dekel Gelbman said in a statement that combining his company’s technologies with Ambry’s genetic testing services will facilitate a “new age in precision medicine.” Read more
